A single cycle of CCK2R-targeted PRRT, e.g., in high risk patients after thyroidectomy and neck dissection, might improve the chances of achieving biochemical remission and allow the assessment of metastatic disease by post-therapy scintigraphy. Here, CCKBR is linked to metastatic neoplasm.